An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has p...
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
About this item
Full title
Author / Creator
Wang, Xinling , Sun, Lujia , Liu, Zezhong , Xing, Lixiao , Zhu, Yun , Xu, Wei , Xia, Shuai , Lu, Lu and Jiang, Shibo
Publisher
United States: Taylor & Francis Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Taylor & Francis Ltd
Subjects
More information
Scope and Contents
Contents
The threat to global health caused by three highly pathogenic human coronaviruses (HCoV), SARS-CoV-2, MERS-CoV and SARS-CoV, calls for the development of pan-HCoV therapeutics and vaccines. This study reports the design and engineering of a recombinant protein designated HR1LS. It contains three linked molecules, each consisting of three structural...
Alternative Titles
Full title
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f63b90c1d24c4785b7803be4cbbbeed0
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f63b90c1d24c4785b7803be4cbbbeed0
Other Identifiers
ISSN
2222-1751
E-ISSN
2222-1751
DOI
10.1080/22221751.2023.2244084
